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Abstract 
Streptomyces a gram-positive filamentous bacteria, that is widely distributed in most soils and 
decaying vegetation. Most Streptomycetes reproduce by spores and distinct for their earthy odor 
that result from the production of a volatile terpene called geosmin which is one of the most famous 
metabolites that are produced by this genus. The discovery of streptothricin in 1942 was the 
starting point of history of antibiotics derived from Streptomyces, and then the discovery of 
streptomycin two years later, after which scientists intensified research’s for antibiotics within the 
genus. Today, a large number of antibiotics are produced by the genus Streptomyces, producing 
antibacterial, antifungal, and antiparasitic drugs, and also a large number of other bioactive 
compounds, such as immunosuppressants. It is thought that the productions of the bioactive 
compounds produced by Streptomyces are initiated during the time coinciding with the aerial 
hyphal formation from the substrate mycelium.  
Streptomycin and oleandomycin are examples of antimicrobial compounds against tuberculosis 
that are produced by Streptomyces griseus and Streptomyces antibioticus respectively. FK506 an 
immunosuppressant is another bioactive compound that is produced by Streptomyces 
tsukubaensis, while avermectin, bleomycin, and daunomycin are antitumor compounds that are 
produced by Streptomyces avermitilis Streptomyces verticillus and Streptomyces peuceticus 
respectively. 
In this research, Streptomyces pratensis QUBC97 was isolated on CCG medium and identified by 
molecular methods. The isolate produced an antibacterial agent when grown in CCG broth that 
showed tow distinguishable compounds from fresh or old cultures. The freshly produced 
compound was extracted in n-butanol and showed an Rf value of 0.86 when developed on silica 
gel TLC plates in n-butanol saturated with 1.7% ammonium acetate. The compound absorbed 
visible light at 426 and 440 nm. Putative identification of HPLC purified and concentrated 
compound using mass spectroscopy suggested the compound to be methoxy, 1-phenyl-, oxime.  
This work is a step in the direction of developing our capacity in detection, isolation, and 
industrialization of antimicrobial agents.  
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Chapter 1 
Introduction 
 
Streptomyces, is a genus of Gram-positive bacteria that belongs to the phylum Actinobacteria and 
forms branching filaments. They have high guanine and cytosine content in their DNA(Tsai et al. 
2008). Historically, the Actinomycetes were thought to be true fungi, because of their formation 
of mycelia branching filaments (hyphae) (Osman, Fath Allah, and Abd El All (2011). The 
similarities to fungi are the result of adaptation of similar ecological environments and a 
saprophytic life. Streptomyces species are complex; they grow as branching mycellia, they 
reproduce in a mold-like manner by sending up aerial branches that turns into chains of spores. In 
soil, they are noted for their distinct earthy odor that results from production of a volatile 
metabolite, geosmin: an organic compound that has an earthy taste and aroma. 
 But unlike the true fungi, Actinomycetes have thin hyphae about 0.5-1.5 micrometers in diameter 
comparing them to fungi hyphae and they also have a prokaryotic ribosome. They are affected by 
antibacterial antibiotics as well. 
 Actinomycetes are known to have various shapes; the simplest is unicellular spheres and rods, 
others are filamentous. Some species of Streptomyces are plant and animal pathogens (Flardh and 
Buttner 2009). Streptomyces are an uncommon cause of infection in human, but they may cause 
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superficial disease after traumatic inoculation. They also cause mycetomas in the feet of farmers 
and perianal soft tissue infections (Chavez, Estrada, and Bonifaz 2002). In Human 
Iimmunodeficiency Virus (HIV) and immune compromised individuals uncommon visceral 
diseases are seen (Kapadia, Rolston, and Han 2007; Rose, Brown, and Fisher 2008). 
Among the genera of Actinomycetes, Streptomyces is the largest genus that produces antibiotics, 
producing both antibacterial and antifungal, as well as a wide range of other bioactive compounds 
such as immunosuppressants (Watve et al. 2001).  
Due to the emergence of antibiotic resistant bacteria due to intensive use of antibiotics within 
months and years, identification of new antimicrobial agents is very important.  Streptomyces are 
important for the discovery of new antibiotics, mining of uncovered natural product biosynthetic 
clusters in bacterial genomes, and inhibitors of antibiotic resistance such as sulbactam clavunilic 
and dipicolinic acid (Spellberg et al. 2004).  
This current research focused on one isolate of the Streptomyces QUBC97 and its antibacterial 
active compound. 
 
1. Literature review 
Antibiotic production by microbes 
 
1.1 Actinomycetes 
 
The full Lineage of Streptomyces as posted by ('NCBI') 
Super kingdom: Bacteria 
Phylum: Actinobacteria; contain a single class: Actinomycetes 
Order: Streptomycetales;  
Family: Streptomycetaceae;  
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Genus: Streptomyces which includes 778 species and 38 subspecies according to (Bacterionet). 
They are branching, prokaryotic Gram positive bacteria. The colonies look like a mass of mycelia 
with branching filament extensions that form spores. Actinomycetes are considered bacteria 
although they lack a defined nucleus. Most of its subspecies are aerobic but there is some species 
that could live under anaerobic conditions. They reproduce by spores and form radial colonies with 
pigments. 
Genus Streptomyces is the most complex in the Order: Actinomycete. Streptiomyces Species are 
found almost everywhere, although they prefer alkaline and neutral conditions and the optimal pH 
ranges between 7 and 8. Most Streptomyces grow at temperatures between 15 and 30° C; while 
there are species that live at higher temperatures (Waksman 1953). 
 
1.2 History of Streptomyces and antibiotics 
 
In the 1940s, Streptomyces description was confirmed as an aerobic, spore forming genus that also 
produces antibiotic and bioactive compounds. Actinomycin was isolated by Waksman and 
woodruff from Streptomyces antibiotica. Since then, many investigators established isolation of 
antibiotics from many culture media of Streptomyces species. A rich period started in which many 
useful antibiotics were isolated and reported from Streptomycetes. The importance of 
Streptomyces is due to their ability to produce important bioactive metabolites such as antibiotics, 
antifungal,antitumar and antiparasitic agents; Streptomyces avermitilus produces the antiparasitic 
compound Ivermectin. (Osman, Fath Allah, and Abd El All 2011; Flardh and Buttner 2009). 
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  1.3 Streptomyces and medicine 
 
 The genus Streptomyces is known for the production of a large number of antibacterial, antifungal, 
antitumor and antiparasitic agents, and also a wide range of other bioactive compounds, such as 
immune suppressants (Omura and Crump 2004). Members of the Streptomyces genus are the 
source for numerous antibacterial pharmaceutical agents; Chloramphenicol is an example of 
bacteriostatic antibiotic that is produced by Streptomyces venezuelae, while Streptomycin the first 
drug of choice used as tuberculosis treatment is produced by Streptomyces griseus. Tetracycline a 
broad spectrum antibiotic used to treat many bacterial infections is produced by Streptomyces 
rimosus and Streptomyces aureofaciens. There are more bioactive compounds such as avermectin, 
bleomycin, and daunomycin  which are produced by Streptomyces avermitilis (Burg et al. 1979), 
Streptomyces verticillus (Umezawa et al. 1968), and Streptomyces peuceticus (Arcamone et al. 
1969) respectively that are used as antitumor compounds,  while tacrolimus (FK506) from 
Streptomyces tsukubaensis as an immunosuppressant that inhibit calcineurin (Kay 1996), and 
validamycin from  Streptomyces hygroscopicus is used as a treatment of heath blight disease in 
rice (Watve et al. 2001). 
 
1.4 Culturing of Streptomyces 
 
Media labeled as ISP 1, 2, or 4 are used for characterizing Streptomyces species according to the 
International Streptomyces Project (ISP). ISP media were developed by Difco Laboratories for the 
International Streptomyces Project (ISP) in order to introduce stable properties and reliable 
procedures for characterization of Streptomyces species. ISP Medium 1 contains Tryptone-Yeast 
Extract Broth; peptone and yeast extract provide nitrogen, vitamins, carbon and amino acids. ISP 
Medium 2 is also called Yeast Extract-Malt Extract Agar, Yeast extract and malt extract provide 
nitrogen, amino acids, and vitamins, while dextrose is the carbon source. ISP Medium 4 which 
also called Inorganic Salts-Starch Agar is composed of many inorganic salts like calcium chloride 
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and soluble starch to provide the essential nutrients for organism growth. Agar is the solidifying 
agent for all ISP media (Gottlieb and Shirling 1966). 
Streptomyces needs carbon and nitrogen in order to grow, so new CCG medium was used to culture 
Streptomyces (Barghouthi and Qadi 2012). Glycerol is the main carbon source, while casein 
provides the nitrogen requirement under artificial conditions. Trace minerals such as NaCl, 
K2HPO4, MgSO2•7H2O, CaCo3 and FeSO4.7H2O are also necessary. In a few cases, antifungal are 
added to the culture in order to eliminate fungi and general bacteria from plates. Previous studies 
used copper to inhibit growth of algae, bacteria, fungi and other aquatic species that could be 
present in the samples. Incubation temperature is at 30 oC, and the pH 7.5 the media could be solid 
or broth media. 
 
1.5 Secondary metabolites 
 
Streptomyces spp. produces secondary metabolites including compounds that have important 
applications in medicine as antibacterial, antiviral, antiparasitic, and antifungal agent. Also, in 
agriculture these compounds act as growth promoters, agents of plant protection, and herbicides 
(Demain and Fang 1995). 
The production of antibiotics by Streptomyces grown on agar or liquid media usually coincides 
with the early stages of morphological differentiation of the aerial hyphai (Waksman 1953). 
One of the most important streptomycetes is Streptomyces coelicolor; many researches were done 
on it because it produces about five secondary metabolites, four of them have antibiotic activity; 
the colored and visually detected actinorhodin, undecylprodigiosin, methylenomycin, and the 
calcium dependent antibiotic (CDA) (Procopio et al. 2012). The aromatic polyketide actinorhodin 
is the best example of all Streptomyces antibiotics according to the change of color depending on 
the PH of the environment: blue in neutral and alkaline solutions and red in acidic. 
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1.6 Inhibitors of antibiotic resistance 
 
Calvulanic acid, Sulbactam, Tazobactam, and Avibactam are compounds produced by 
microorganisms that play an important rule of protecting the familiar beta-lactam antibiotics from 
hydrolysis by penicillinases or broad-spectrum beta-lactamases, by adding those inhibitors to a 
safe and efficacious penicillin’s or cephalosporin’s for better results. 
Some bacteria can produce extended spectrum β-lactamases (ESBLs) that breaks the beta- lactam 
ring that allows the antibiotic to work, which makes the infection more difficult to treat because 
of their resistance to penicillin’s and cephalosporin’s. Inhibitors of beta-lactamases acts by binding 
to the active site of the enzyme preventing it from binding to the lactam ring and damaging it 
(Drawz and Bonomo 2010). 
 
1.7 Oxime 
 
The oxime term refers to the combination between oxygen and imines. Oxime is an imine 
moleculewith a general formula R1R2C=N O H, where R1 is an organic side-chain and R2 may be 
hydrogen or any other organic group.it could have stereoisomers  according to the both side 
chains of the molecule attached to the carbon and which side is closer to the carbon. 
Bacterial drug resistance played an important role in the failure of treatment of many resistant 
bacterial infections. As bacterial resistance increased, the search for new antibacterial agents was 
important and urgent. Scientists started to study of oxime-ether derivatives in the recent years due 
to their anti-bacterial, antiprotozoan, antifungal, and antimicrobial activities. Different oxime-
ether derivatives have also been reported to insecticidal activities. One example of oximes, 5-keto-
5-oxime which is derivative of the anti helmentic and insecticidal milbemycins that exhibited high 
activity as anti-microfilariae in dogs. Oximes are produced in nature mostly, but not exclusively, 
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as intermediates of secondary metabolites by enzymic oxidation of an amine function (Rappoport 
and Liebman 2008). 
 
1.8. Streptomyces pratensis 
 
Streptomyces flavogriseus IAF-45-CD (=ATCC 33331), a strain recently reclassified as 
Streptomyces  pratensis which has been isolated recently  from a wide region of North America  
in North Carolina, New York, Michigan, and Quebec. Despite different geographic origins, the 
genomes of the two strains are highly similar with 85.9% of genes present in the core genome and 
conservation of all natural product gene clusters. This strain includes a combination of two genes 
that codes for carbapenem which is used to treat infections caused by multidrug resistant (MDR) 
bacteria, and beta-lactamase inhibitor gene that codes   for beta-lactamase inhibitor which bind to 
the active site of the enzyme that damages the lactam ring and prevents the antibiotic from working 
on bacteria, in addition to other genes that are required for spore development and antibiotic 
production. while other genes includes uncharacterized protein which may function as toxin-
antitoxin system (Doroghazi and Buckley 2014). 
The nucleotide divergence of multi-locus sequence analysis from strains of Streptomyces pratensis 
did not exceed 0.4% justifies their inclusion in a single species as Steptomyces pratensis showed 
a very high recombination. Recombination of interspecies among Streptomyces species is 
widespread; the high level of nucleotide similarity within different species provides evidence about 
the gene exchange (Berdy 2005). 
 
1.9 Hypothesis 
 
Streptomyces and other soil bacteria have to survive in harsh environment with changing variables 
and unstable conditions. The large number of Streptomyces species present in soils and other 
environments is a strong indicator of its survival strategies; some have not been classified yet 
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(Unclassified Streptosporangineae sinosporangium). This may encompass the production of 
antibiotic agents including antibacterial, antiviral, antifungal, antiparasitic, and anti protists, and 
other bioactive agents. The hypothesis is that several bioactive agents produced by Streptomyces 
have not been discovered yet and are awaiting discovery. 
 
 
1.10 Problem statement 
 
Months or years of misuse and bacterial exposure to antibiotics, select for antibiotic resistant 
bacteria which become dominant especially in health care centers. Identification of new 
antimicrobials and new antimicrobial targets is a continuous requirement in controlling 
pathogenic microbes. Streptomyces with its 778 spp and 38 subspecies represents a reservoir that 
has not been fully and systematically investigated, and as an important source of bioactive agents 
including antibacterial antibiotics. Therefore it is important to search for new antibiotics and 
inhibitors of antibiotic resistance amongst the Streptomyces.  
 
1.11 Aim 
 
The goal of this research is to establish and explore new methods that are necessary for detection, 
production, and enhancing production of new antibiotics and their possible applications. This 
project represents a starting point in that direction. 
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Chapter 2 
Materials and methods 
. 
2.1 Isolation and culturing of Streptomyces 
 
Soil and other samples were collected from various locations around the world to obtain 
representative samples and to reduce repetitive isolation of the same isolate or species. The soil 
samples (200-300 g) were collected from a depth of five centimeters in fresh plastic bags and 
stored at room temperature. 
The samples were first cultured on CCCG selective agar medium (pH ~7.8 before autoclaving) for 
Streptomyces isolation, and the CCG medium was prepared as follows: Casamino acids (0.1%, 
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proteolytic hydrolysate of casein; Sigma Chemicals), 0.1% sodium citrate, 2% agar made in 
Jericho® bottled water as a source of trace elements, autoclaved and cooled to ~50º C. Both broth 
and solid (2% agar) media were autoclaved for 18 minutes; glycerol was aseptically added to other 
components after autoclaving. Addition of cyclohexamide (100µg/ml) was initially used to obtain 
pure isolates of Streptomyces, and hence the medium was labeled as CCCG; cyclohexamide was 
only used in the early stages of Streptomyces isolation. CCG was used both as broth or agar for 
the evaluation of antibacterial and antiyeast bioactivities of Streptomyces spp. Nutrient broth and 
agar were from BD Difco (United States). Plated samples were incubated at 28°C until colonies 
could be microscopically discerned. The colonies were subcultured on CCG medium and pure 
colonies were obtained after 5 days for repeated subculturing for more purification. Grown pure 
colonies were then inoculated to a liquid CCG culture medium in flasks on a shaker (120 rpm) at 
28°Cfor 1-3 weeks. Direct microscopic examination was used at 4x and 10x objective lenses to 
distinguish fungi from putative Streptomyces for further identification. 
 
2.2 Characterization of the isolates 
 
The Streptomyces isolates were cultured on BD Difco ISP4 medium. This medium is 
recommended by ATCC to use in colony and pigment characterization according to the 
international Streptomyces project ISP. The phenotypic characteristics of the isolates were 
evaluated as QUBC97 in this study. Cultured samples were evaluated for the shape of the colonies, 
and the color of pigmentation of the colonies on ISP4. Shape of cells was studied under light 
microscope with 4x and 10x objectives, photographed with (3-12) Mpix digital camera (Exilim, 
Casio, Japan). 
2.3 Manipulation of culture productivity of the antibacterial agent 
First CCG liquid medium was prepared and inoculated with 1 loop-full of QUBC97 and incubated 
with shaking (120 rpm) at 28°C, then 1ml of the medium was collected every 24 hours for a total 
of 7 collections, centrifuged, then extracted with 0.5ml n-butanol, the extracted layer was tested 
for antimicrobial activity using sterile filter paper discs. This technique was repeated every day 
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over 7 days to study the production of the antibacterial agent by studying the diameter of the zone 
of inhibition. Three filter paper discs were impregnated with the extract and placed on the surface 
of NA coated with Bacillus atrophaeus, diameters of zones of inhibition were measured and 
recorded (Barghouthi and Salman 2009). 
2.4 Evaluation of production of antibacterial agent(s) 
 
2.4.1 Agar plug diffusion test 
 
Three quick and simple antibiotic production screening tests were devised. First Streptomyces 
isolates were allowed to grow for up to 4 weeks at 28° C.  A glass Pasteur pipette was kept in 70% 
alcohol, drained, then flamed and allowed to cool, and then used to cut agar plugs near heavy zones 
of growth. Agar plugs were removed and placed on the top of  a nutrient agar (NA) plate that has 
been coated with a layer of the test-organisms   ( Bacillus atrophaeus QUBC16 or the baker’s yeast 
Sacchromyces cerevisoae).  There plates were then incubated for 24 hours upside down at 30°C. 
A zone of inhibition surrounding the agar plug was considered as a positive indication of 
antimicrobial production by the isolated Streptomyces. The method was repeated for confirmation 
of results.  
 Aliquot of 1 ml was collected from each isolate that was inoculated into 50-ml liquid CCG 
medium in Erlenmeyer flasks and incubated on a shaker (120 rpm) at 28°C for one week and 
centrifuged to obtain a clear supernatant, which was removed to another 1.8 ml microfuge tube 
and extracted with 0.5 ml n-butanol and vigorous shacking followed by brief centrifugation. The 
butanol-antimicrobial agent top layer was removed for testing. 
Another way of separation of antimicrobial agent was as follow: medium was adsorbed to a solid 
phase from talcum powder then eluted with a reduced volume (20-25% of the original volume) of 
methanol. Ten µl of extracted layer from both methods were used to impregnate a sterile filter 
paper disc, dried, and then placed on NA plates that have been coated with a layer of the test-
organism. Plates were incubated overnight at 30°C and examined for production of inhibition 
zones. 
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2.4.2 Extraction of antibacterial agent(s) 
 
Antimicrobial substance was recovered from liquid medium by two ways; 1-butanol extraction, 
and 2- solid phase using talcum powder. 
Streptomyces QUBC 97 was grown in 2x 750 ml of CCG medium in 2-liter flasks with shaking 
(120 Strokes /min) for 2 weeks. After centrifugation of the culture medium in 6x30 ml tubes per 
each run, at 25,000 rpm for 15 min, supernatant was pooled and transferred to a separatory 
funnel, n-butanol was added in a ratio of 1:4 (v/v), vigorous shaking was applied to guarantee 
extraction. After 24h the upper layer was collected. A second washing step was performed to the 
culture medium in the separatory funnel; n-butanol was pooled from both extractions, and 
evaluated for antimicrobial activity using disc diffusion technique. This product was labeled 
crude n-butanol extract (cnBE). Concentration of cnBE was carried out to near dryness using a 
rotary evaporator at 50-60˚C. The dried substance obtained after evaporation was collected in a 
pre-weighed tube and weighed. The product was subjected to HPLC purity testing and further 
purification using preparative HPLC.  
 
2.4.3 Magnesium silicate solid phase extraction 
 
The second method was using talcum powder (magnesium silicate) as a solid phase to extract the 
antimicrobial substance.  The talcum powder had been washed with highly pure sterile water (PCR 
water) several times to remove any soluble component before use. Culture supernatant (30 ml) 
obtained after centrifugation was mixed in a flask and stirred for 15 min. to ensure adsorption of 
the antibacterial substance to the silica, and then the talcum was allowed to settle for 24 h. The 
supernatant was removed and kept at room temperature. 10 ml of methanol was added to the 
precipitated powder, mixed, covered, and then left for the next day. The methanol layer was 
recovered and its antimicrobial activity was tested. 
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2.4.4 HPLC of cnBE 
 
The dried material was dissolved in water and subjected to preparative HPLC purification. The 
water eluate was collected and tested for antibacterial activity by the disc diffusion method. The 
two positive fractions (50ml each) were pooled and re-extracted with n-butanol from the aqueous 
HPLC column fractions and concentrated by rotary evaporation. The dried material was re-
suspended in 1 ml pure water for analysis by mass-spectroscopy for putative identification. 
 
2.5 Testing the n-butanol extracted from QUBC 97 against tested microorganisms 
 
The n-butanol extracted from a large scale (1.5 liter CCG broth culture) was subjected to testing 
against a number of bacterial species using disc impregnation and diffusion test. The dried discs 
were placed on lawns of NA plates of the following bacterial species Staphylococcus 
epidermidis, S. aureus, Streptococcus viridians, S. pyogenes, S. aglactiae, Bacillus atrophaeus, 
Escherichia coli (several isolates), E. coli HB101 laboratory strain, and several isolates of 
Pseudomonas aeruginosa. Baker’s yeast was also used. 
 
2.6 Thin layer chromatography (TLC) 
 
Silica gel plates were cut to short strips (1x8 cm), the test compound was spotted about 0.5cm 
above the lower edge of the strip. Suitable volumes of n-butanol extract (5-15 μl) were spotted 
slowly allowing the formation of a small tight spot using a sterile clean 200- μl pipetting tip. 
After drying, the TLC strips were developed in different solvents. The solvent systems were 
prepared according to HEMW (Hexane, ethyl acetate, methanol, and water); Table A.1. Another 
solvent was used; n-butanol saturated with 1.7% ammonium acetate solution where the upper 
layer was used (Barghothi et al. 1991). The ratio of distance moved by the solvent and solute 
along the paper, from the origin baseline was measured to defined the Rf   value 
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The developed strips were allowed to dry after marking the solvent front and studied under UV 
light. Antibiotic activity was determined by placing the TLC strips; face down, on a lawn of 
target organism spread on NA plate. 
 
2.7 Identification of the isolate QUBC 97 
 
It was important to identify the bacterium QUBC 97 for literature search, comparison purposes, 
and documentation. In addition to the Morphological appearance, 16S PCR with specific primers, 
superoxide primers specific for the genus Streptomyces and PCR product DNA sequencing 
followed by BLAST analysis to confirm and identify the QUBC 97 species. Primers used were 
Streptomyces specific primers with a general 16S primer see Table A.2. 
Standard PCR method was optimized. The reaction conditions were as following:  initial 
denaturation by hot start at 95 °C for 2 min, followed by 31 cycles of denaturation at 94° C for 90 
s, annealing for 30 s at 60° C and 30 sec. at 58° C respectively and extension at 72°C for 105 s. A 
final extension at 72°C for 2 min. using commercial master mix  from Promega Biochemical 
Company, which contains  Taq DNA polymerase, dNTPs, MgCl2 and reaction buffers at (2X) 
concentrations. Reaction products were electrophoresed in a 1.5% agarose gel stained with 
ethidium bromide and visualized and photographed under UV light. . 
Selected amplicons were extracted using commercial Kit (NeucleoTrap, Mecherey Nagel, 
Germany) and sequenced (Bethlehem University, Bethlehem, Palestine) followed by BLAST 
alignment for species identification. Sequencing of ribosomal amplicon and Superoxide amplicon 
to compare sequencing based grouping to Multilocus Generated Clustering (Qadi 2012).  
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Chapter 3 
Results  
 
3.1 Isolation of Streptomyces species 
 
When soil samples were cultured on NA plates and incubated for more than 3 days, filamentous 
colonies were observed. Microscopic examination of suspected colonies suggested Streptomyces 
nature due to fine filamentous mycelia that were not confused with fungal mycelia. Isolates were 
subcultured on CCG and ISP4 media for further macroscopic and microscopic monitoring figure 
(3.1).  
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Figure 3.1: Streptomyces versus Fungus at 10x objective microscopic  
 
3.2 Descriptions of Streptomyces isolates  
 
Using the agar plug diffusion assay, QUBC97 was selected for further investigation due to its fast 
and stable growth, storage, and relative large zone of inhibition of Bacillus atrophaeus QUBC16 
relative to other isolates; two other isolates were included, one of them was slow grower QUBC 
293 (orange pigment producer on CCG) and the other QUBC 167 (blue ink diffused pigment 
producer on CCG) was inconsistent in producing antibacterial activity. Colonies of isolate 
QUBC97 were white colonies when grown on CCG Figure (3.2A) or ISP4 Figure (3.2C), yellow 
pigmentation of the lower side of colony and diffused yellow product on CCG Figure (3.2B) or 
ISP4 Figure (3.2D). The opaque nature of ISP4 due to its starch and calcium chloride content 
dimed the brightness of the yellow pigmentation relative to the transparent CCG agar. The low 
complexity of CCG medium allowed studying antimicrobial productivity and simplified agent 
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extraction with relative high purity, since there was little interference from the components of the 
medium. 
 
 
Figure 3.2: Isolate QUBC97, white colonies when grown on CCG (A) or ISP4(C), yellow 
pigmentation of the lower side of colony and diffused yellow product on CCG (B) or ISP4 (D). 
White square (B) indicates location of agar plugs (colony free areas close to colonies). The 
opaque nature of ISP4 due to its starch and calcium chloride content dimed the brightness of the 
yellow pigmentation relative to the transparent CCG agar. 
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3.3 Testing for antibiotic activity: 
 
3.3.1 Agar plug diffusion test 
 
 Agar plugs were cut out from CCG agar plates after 14 days that showed good growth of pure 
cultures of putative Streptomyces isolates, antibiotic diffusion into the agar allows usage of agar 
as in disc sensitivity tests. The agar plugs were placed on lawns of Bacillus atrophaeus QUBC16 
spread evenly on nutrient agar and incubated at 28°C, Figure (3.3) shows QUBC97 and two other 
isolates that produced antibacillus agents. QUBC97 was selected for further investigation due to 
its fast and stable growth, storage, and relative large zone of inhibition. 
 
 
 
Figure 3.3: Three different Streptomyces isolates showing inhibition zones around agar plugs, 
against bacillus isolate Bacillus QUBC153 (unidentified) whereas Bacillus QUBC142 was not 
responsive to any agar plug. Including QUBC97 which was selected for further investigation. 
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3.3.2 Filter paper disc sensitivity testing 
 
Organic extraction of QUBC97 cultures (from agar plates or broth media) was performed using n-
butanol due to its miscibility with water and low volatility. N-butanol extract was used to 
impregnate sterile filter paper discs with (10 µl), after drying, sensitivity testing against test-
organisms was carried out. The technique was more reliable than solid phase extraction (with 
talcum powder) due to time and cost saving and poor recovery of antibiotic agent. Diameters of 
zones of inhibition Figure (3.4). 
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Figure3.4: Panel I; Control discs of blank (Bk), n-Butanol wet (W) (10 µl ) or after air drying (D) 
on three bacterial species. Panel II; activity of n-butanol extracted antibiotic against different 
microorganisms, using impregnated filter disc diffusion technique. No inhibition of wild type 
Pseudomonas isolates, Escherichia coli DH5α, or baker’s yeast, but was inhibitory to Gram 
positive bacteria and E.coli HB101. The antibiotic profiles for these bacteria were not determined.   
 
Zones of inhibition using n-butanol extracts of QUBC97 are shown in figure (3.4) for Bacillus 
atrophaeus, Staphylococcus epidermidis, Staphylococcus aureus, Streptococcus pyogenes, 
Streptococcus aglactiae, Escherichia coli DH5α, and baker’s yeast. 
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3.3.3 Kinetics of antibiotic production 
 
Longitudinal sampling of liquid culture medium every 24 hours for seven days followed by 
extraction with n-butanol, and disc diffusion assay against B. atrophaeus QUBC16 revealed 
varying zones of inhibition. Diameters of zones of inhibition were considered as a direct 
reflection of the concentration of antibacillus agent. For each time point 3 discs were prepared, 
and diameters of zones of inhibition were measured after 24 h incubation at 28°C. The results are 
presented in Table (3.1) and Figure (3.5). 
The production of the antibiotic starts after 24 hours of incubation and increases with time until it 
reached the maximum diameter of zone of inhibition. Further study is needed to determine 
substances and conditions that may induce the productivity. 
 
Table3.1: Kinetics of antibiotic produced by QUBC97 as assayed against Bacillus 
atrophaeus QUBC16 
Day Diameter of  zone of 
inhibition in (mm) 
2nd Diameter of  zone of 
inhibition(mm) 
3rd Diameter of  zone of 
inhibition(mm) 
Average +/- 
SD 
1 8 8 9 8.3 ±0.0.57 
2 15 15 15 15±0 
3 18 18 17 17.7 ±0.57 
4 20 20 20 20±0 
5 21 20 21 20.7±0.57 
6 21 21 21 21±0 
7 21 21 21 21±0 
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Figure 3.5: Kinetics of antibacillus production by QUBC97. Maximum production under 
indicated conditions can be achieved after ~130 h where it stabilized at 21 mm. Error bars indicate 
standard deviation from the mean.  
 
3.4 TLC analysis of butanol extract 
 
The recovered n-butanol extract from agar plates of QUBC97 was analyzed using chromatography 
on silica gel TLC plates. The results showed that two compounds can be separated into two 
bioactive spots when TLC was developed in n-butanol saturated with 1.7% ammonium acetate 
(nBAAc). In nBAAc, two spots were active Rf = 0.58 and 0.895. In water: methanol (1:1 v/v), Rf 
was 0.17 and another product showing as a streak along the TLC strip figure (3.6) 
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Figure 3.6: Agar plate of QUBC97 grown on CCG extracted with n-butanol. (A) Left strip of TLC 
was developed in methanol:water (1:1), spot 1A Rf=0.17 and a long streak of inhibition. (B) Was 
developed in nBAAc, spot 1with Rf = 0.58 and spot 2  Rf=0.895. The disc (3) diffusion test 
showing a diameter of 22mm of 5µl extract.  TLC plate (UV photo) showed an orange/yellow spot 
that coincides with the slow moving activity at 22mm (B, spot 1) from TLC base line (*) suggesting 
the yellow diffused substance to be the active component or that co-purifies with the active 
component. 
 
However when the bacterium QUBC97 was grown in liquid medium only one product could be 
extracted in the n-butanol. Therefore, liquid media provided a simple method to obtain one of the 
products for further analysis; two spots may due to an intermediate compound of the same 
antibiotic since it disappeared from liquid medium. In agar, modification of a product that diffuses 
away from the bacterium is not possible, which may explain the two compounds. Another 
possibility is that the two compounds are not related. Yet when liquid culture was kept for 6 months 
and reextracted with butanol, a single but a different compound with a different Rf was observed. 
Figure (3.7) 
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Figure3.7: Fresh and old n-butanol extracts were spotted separately (not shown) or co-spotted on 
the same TLC strip and developed in nBAAc to reveal complete separation of the two activities. 
Zone of inhibition depended on the amount of each fraction that was spotted on the TLC.  
 
The n-butanol extract of liquid medium showed an Rf value of 0.3 when developed in a polar 
solvent (+6 a mixture of Hexane:Ethylacetate: methanol:water; 2:8:2:8, see Table (A.1) in 
appendix. Better mobility was obtained when TLC were developed in a less polar solvent (-2) 
which contained Hexane:Ethylacetate: methanol:water (7:3:5:5) Rf  was 0.72. (liquid phase). The 
slower (old sample) with Rf =0.65 showed split absorption peak at λ426 and λ444 nm and faster 
(fresh sample) with Rf =0.86 as shown in Figure (3.8).  
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Figure 3.8: (A) Old Sample with slow mobility at 0.58 in nBAAc UV-Vis scan showing split peak 
absorption of blue light at 426nm and 444 nm. (B) Fresh sample with fast mobility at 0.86 in 
nBAAc UV-Vis scan showing split peak absorption of blue light at 428nm and 443nm. The 
complementary color for both peaks is yellow. 
 
3.5 Identification of QUBC97 Streptomyces species 
 
Figure 3.9 shows the PCR amplicons and superoxide dismutase as well as other Streptomyces 
specific amplicons for two isolates; QUBC188 and QUBC97 with different patterns. Sequencing 
of both Superoxide amplicon (333bp) and the 16S amplicon and BLAST analysis were used to 
determine and confirm the identity of putative QUBC 97 isolate. BLAST showed that QUBC97 
was most likely identical to Streptomyces pratensis ATCC 33331. Morphologically, the isolate 
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was found to agree with Waksman’s description of S. flavogresius; which was recently renamed 
as Streptomyces pratensis (Waksman 1953). BLAST Sequence alignment showed 100% identity 
of the PCR amplicon to Streptomyces pratensis.  
StmyF.Rn3 and SOXD PCR amplicons of QUBC97 were sequenced using automated sequencing 
services (Bethlehem University, Genetics Lab, Bethlehem, Palestine), the sequences were 
manually edited Figure (3.9) and assembled then analyzed using online Nucleotide BLAST 
services.  BLAST alignment of 16S ribosomal amplicon suggested that QUBC97 closely matched 
Streptomyces pratensis ATCC 33331. 
 
 
 
Figure 3.9 (A): Gel electrophoresis (1.6% agarose) showing multiple bands generated for two 
separate Streptomyces isolates ; the control isolate QUBC188  (lanes 1,2,and3) and the test 
isolate QUBC97 (lanes A,B, and C); the band above the asterisk is the Superoxide dismutase 333 
bp which appears in both lanes 1 and A. 
The second band in lane A is a 640bp amplicon of 16S generated by QUGPFn6 and the 
Streptomyces specific Reverse primer (SMycR);. Another 670bp band was generated with 
SMycF and QUGPRn3 for sequencing (right side gel, Figure 3.9A). 
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SMycF.Rn3 amplicon: 
ATGCTGCAACAGAAGGGTTGCGCTCGTTGCGGGACTTAACCCAACATCTCACGACACGAGCT
GACGACAGCCATGCACCACCTGTATACCGACCACAAGGGGGGCACCATCTCTGATGCTTTCC
GGTATATGTCAAGCCTTGGTAAGGTTCTTCGCGTTGCGTCGAATTAAGCCACATGCTCCGCTG
CTTGTGCGGGCCCCCGTCAATTCCTTTGAGTTTTAGCCTTGCGGCCGTACTCCCCAGGCGGGG
AACTTAATGCGTTAGCTGCGGCACCGACGACGTGGAATGTCGCCAACACCTAGTTCCCAACGT
TTACGGCGTGGACTACCAGGGTATCTAATCCTGTTCGCTCCCCACGCTTTCGCTCCTCAGCGT
CAGTAATGGCCCAGAGATCCGCCTTCGCCACCGGTGTTCCTCCTGATATCTGCGCATTTCACC
GCTACACCAGGAATTCCGATCTCCCCTACCACACTCTAGCTAGCCCGTATCGAATGCAGACCC
GGGGTTAAGCCCCGGGCTTTCACATCCGACGTGAACAAGCCCGGCCCTACCGAGCTCTTTAC
GCCCAATAATTCCGGAACAACGCTTTGCCGCCCCTAACGTATTACCGCGGGCTTGCTGGCACG
TAGTTACGCCGGCGCTTCTTTCTGCAAGGTACCGTCATCTTTT 
 
Superoxide dismutase amplicon: 
 
 
Figure 3.9 (B): Nucleotide sequences edited and assembled from both forward and reverse 
sequences of the SMycesF and QUGP Rn3.  
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Figure 3.9 (C ):  Nucleotide sequence BLAST identified Streptomyces flavogriseus strain ATCC 
33331with 99.4% 16S identity; the bacterium was recently renamed Streptomyces pratensis. 
 
3.5 HPLC purification 
 
HPLC separated one peak in about 100ml pure water eluate due to the polarity of the relative low 
polarity of the product, three fractions were tested for antibacterial activity after being re-extracted 
in n-Butanol. The rextracted layer was collected and 10µl from each fraction were spotted slowly 
on silica gel strips then allowed to dry and were developed in solvents -2 and -6 to give Rf=0.762 
and Rf=0.30 respectively. 
Streptomyces flavogriseus strain ATCC 33331 16S ribosomal RNA gene, complete sequence  
Sequence ID: ref|NR_074559.1|Length: 1514Number of Matches: 1 
Range 1: 193 to 694 GenBank Graphics Next Match Previous Match  (Matched many spp., not specific) 
Query  1    AAAAGCTCCGGCGGTGAAGGATGAGCCCGCGGCCTATCAGCTTGTTGGTGGGGTAATGGC  59 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  193  AAAAGCTCCGGCGGTGAAGGATGAGCCCGCGGCCTATCAGCTTGTTGGTGGGGTAATGGC  252 
Query  60   CTACCAAGGCGACGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGA  119 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  253  CTACCAAGGCGACGACGGGTAGCCGGCCTGAGAGGGCGACCGGCCACACTGGGACTGAGA  312 
Query  120  CACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGAAAGCCT  179 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  313  CACGGCCCAGACTCCTACGGGAGGCAGCAGTGGGGAATATTGCACAATGGGCGAAAGCCT  372 
Query  180  GATGCAGCGACGCCGCGTGAGGGATGACGGCCTTCGGGTTGTAAACCTCTTTCAGCAGGG  239 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  373  GATGCAGCGACGCCGCGTGAGGGATGACGGCCTTCGGGTTGTAAACCTCTTTCAGCAGGG  432 
Query  240  AAGAAGCGAAAGTGACGGTACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCG  299 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  433  AAGAAGCGAAAGTGACGGTACCTGCAGAAGAAGCGCCGGCTAACTACGTGCCAGCAGCCG  492 
Query  300  CGGTAATACGTAGGGCGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCG  359 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  493  CGGTAATACGTAGGGCGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGAGCTCGTAGGCG  552 
Query  360  GCTTGTCACGTCGGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCGATACGGGC  419 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  553  GCTTGTCACGTCGGATGTGAAAGCCCGGGGCTTAACCCCGGGTCTGCATTCGATACGGGC  612 
Query  420  TAGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATAT  479 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  613  TAGCTAGAGTGTGGTAGGGGAGATCGGAATTCCTGGTGTAGCGGTGAAATGCGCAGATAT  672 
Query  480  CAGGAGGAACACCGGTGGCGAA  501 
            |||||||||||||||||||||| 
Sbjct  673  CAGGAGGAACACCGGTGGCGAA  694 
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The eluted peaks was concentrated by rotary evaporator and then analyzed by Mass spectroscopy 
for putative identification of the antibacterial agent. The analysis suggested that the product is 
methoxy,1-phenyl-,oxime Figure (3.10)  
 
Figure 3.10 (A): Culture supernatant HPLC analysis showing a large number of peaks. 
nButanol extract showed a major peak only.  
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Figure 3.10 (B): Masspectroscopy analysis showing the major breakdown products that were 
indivative of Methoxy,1-phenyl-,oxime 
 
 
Figure 3.10 (C ): The chemical structure of MOPO(right) and a related compound included for 
comparison (left). 
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Chapter 4 
Discussion 
 
The isolate QUBC97 was examined macroscopically and microscopically and putatively identified 
as Streptomyces. Similar and stable morphology appeared on both CCG Figure (3.2A) andISP4 
Figure (3.2C) media. The two fold advantages of using CCG, was transparency compared to the 
opaque ISP4 medium, a property that allowed direct examination of agar plates with 10X objective 
lens, and second, its suitability to study growth factors. Identification of QUBC97 as S. pratensis 
was supported by Doroghazi and Buckley, 2014 since they explained the frequent chromosomal 
recombination which causes some variations and makes taxonomy more challenging. The other 
alternative identification was made as S. griseus. However PCR amplified an amylase amplicon 
from QUBC97 which on BLAST analysis did not pick any of the S. griseus, so the best 
identification would be as S. pratensis..  
The utilization of agar plugs was utilized as a quick and sensitive method for following up 
antibacterial production. An added advantage was observed, byproducts by QUBC97 were 
accumulated in the agar plug to reflect fresh and older products relative to liquid cultures which 
showed one type of byproduct when fresh (<3 weeks) and another type when old (>2 months). 
Diffusion assay showed the consistent production of antibacterial activity from this isolate, which 
was the reason for selecting QUBC97 for further investigations. 
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Extraction of the antibiotic produced by QUBC97 was better with n-butanol than solid phase 
extraction using talcum powder followed by elution with methanol, due to the lower cost and short 
time. Extraction with butanol needs mixing of broth with butanol or overlaying agar plates with a 
thin film of n-butanol, the process can be repeated for second or third round of extraction if needed. 
Solid phase purification is more demanding and cannot be applied to agar media, hence it was not 
a viable choice with QUBC97. 
Disc diffusion technique was used in semi-quantitative analysis when kinetic studies were 
conducted at different time points of culturing QUBC97 in liquid CCG. This was possible since 
n-butanol extraction was standardized over the seven-day follow up period. Disc diffusion 
conducted on n-butanol extracts was consistent and produced expected results. Zones of inhibition 
were quantitatively consistent and reliably reflected the increased concentration of antibacterial 
agent from older (aged) culture as shown in Figure (3.4). Although the conducted experiments 
were semi-quantitative, they were suitable to provide information on the kinetics of [putative 
Oxime] production, although quantitative tests should be done on Mueller-Hinton agar to compare 
Oxime production in different media and conditions for mass production in future. 
Putative oxime was sufficiently stable in crude n-butanol extract for periods longer than 3 years; 
the same extract was kept at room temperature with no noticeable change in its anti-bacillus 
activity. Disc diffusion results consistently produced zones of inhibition ~21mm regardless of the 
age of product. This important aspect should allow pooling of batches produced within a set frame 
of time. For example batches produced within 3 -6 months that have been extracted into n-butanol 
can be pooled and analyzed, and this property is industrially advantageous.   
There was a noticeable difference between antibacterial activities extracted from agar plates 
(showing two spots with different Rf values of silica TLC developed in n-butanol/ammonium 
acetate solvent system) and liquid culture media. When the bacterium QUBC97 was grown in 
liquid medium only one stable product could be extracted in the n-butanol phase. Therefore, liquid 
media provided a simple method to obtain one of the two products for further analysis; young 
cultures produced a fast moving spot on TLC whereas a slower spot was produced when cultures 
were aged. Possible explanation is that one of the products (the fast moving spot) was an 
intermediary compound that became modified to produce the slower moving product; this explains 
the disappearance of the fast moving compound (FastA) from the medium and the domination of 
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the slow compound (SlowB). In agar, modification of the product was nearly impossible since its 
diffusion away from the bacterial colonies which are confined in place unlike those in shaking 
liquid cultures allows it to escape modification causing the two compounds to co-purify in n-
butanol. Another possibility is that the two compounds are not related, although no evidence exist 
that hint or support such a possibility. Absorbance of the crude extract from old and fresh extracts 
showed similar profiles of split peak absorption at 426 and 444 nm which support the compound 
modification (fast A to slow B) rather than two independent compounds. The split peak may 
represent some form of isomerization of the side chain double bond present in the putative Oxime 
figure (A.1).  
The report shows similar peak split of oxime compounds for oxime and iso-oxime at similar 
wavelengths (Chem 1984).  
 
The activity is more hydrophobic since it can be extracted in n-butanol from aqueous medium. On 
TLC plates the activity moved faster when developed in a less polar solvent system such (mixture 
-2: Hexane: Ethylacetate: Methanol: water ;( 7:3:5:5)) with Rf = 0.72 than when developed in a 
polar solvent; Rf =0.3 (+6; 2:8:2:8) table (A.1).  
TLC plate showed an orange /yellow spot that coincides with the slow moving activity at 22mm 
from TLC base line, suggesting the yellow diffused substance to be the active component or that 
co-purifies with the active component. Yellow color production on plates intensified and 
accumulated as plates aged and become completely yellow within 3 weeks, which is consistent 
with kinetics of antibacterial production from liquid medium assayed by disc diffusion Figure (3.4) 
figure ( A.2). (Blogspot) 
The compound was putatively identified as methoxy-phenyl,oxime as suggested by mass 
spectroscopy, although this needs to be confirmed by other analytical methods to unveil the true 
identity of the anti-bacillus agent. 
 
Although most Gram negative bacteria and yeast were resistant to the putative Oxime, E.coli 
HB101 was responsive and showed a clear zone of inhibition, which can be explained based on 
34 
 
permeability of the [Oxime] into the laboratory strain HB101 but not into wild type Gram negative 
bacteria. The responsiveness of MRSA Staphylococcus aureus to [oxime] is consistent with oxime 
being different from β-lactam antibiotics that are usually not effective against MRSA.  
 
Recommendations 
 
Continuation of this study and utilization of this bioactivity at industrial scale can be of 
important value, especially as oximes have been patented (Quinazolin-oxime derivatives as 
Hsp90 inhibitors (Jackson SE,2013;328:155-240. doi: 10.1007/128_2012_356) 
as inhibitors of Hsp90, a molecular chaperone protein, involved in several microbial and cancer 
diseases, which makes oxime an important compound to study. 
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Appendix 
 
Table A.1:  thin layer chromatography liquid phase table. (Liquid phase)
 
Table A.2: Primers used in detection and identification of QUBC 97(Qadi 2012) 
Primer 
Name 
(F/R) 
Target Gene Sequence 
Tm 
ºC 
Comment/ 
Reference 
 
SMyces F 16S ribosomal gene 5’-GGTCGAAAGCTCCGGCGGTGAA-3’ 60  
SMycesF2 16S ribosomal gene 
5'-CCCTTCACTCTGGGACAAGCCC-3' 
 
61  
QUGP 3R 16S ribosomal gene 
5’-CAGGATTAGATACCCTGGTAGTCC-
3’ 
65  
SOXD-F Superoxide dismutase  5’-GCAGGTAGAAGGCGTGCTCCCA-3’ 63  
SOXD-R Superoxide dismutase 
5’-CCTCGCGTTCCACCTCTCCGG-3’ 
 
63  
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Figure 4.1: oxime isomeration. (oxime isomers) 
 
Figure A.2: a chart of wavelengths of the different colors throughout the spectrum (Blogspot). 
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على وسط زراعة ) sisnetarp secymotpertSفي هذا البحث, تم عزل بكتيريا ستريبتومايسز براتنسز (
). ralucelomعليها بطرق جزيئية ( ) ومن ثم التعرف79CBUQ) والتي سميت بالبحث ( GCCجديد (
تميزت هذه البكتيريا بقدرتها على انتاج مضادات حيوية عند زراعتها على هذا الوسط والتي اظهرت مركبين 
مميزين من عينات قديمة وحديثة مزروعة. العينات المزروعة حديثا ًتم استخلاص هذه المركبات منها عن 
 د عمل فحص استشراب على طبقة سيليكا رقيقة) وعنlonatub-nطريق مذيب البيوتانول(
 044و  624. المركب امتص الضوء المرئي على درجة 68.0 = fR) اعطى نتيجة CLT leg acilis( 
) لتحديد هذا المركب الذي تبين لاحقا انه ypocsortceps ssamو ( )CLPHعمل )نانوميتر وتم 
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 الستريبتومايسزأنواع نشاط المضادات الحيوية لعدد من 
 اعداد: ابتهال محمود ربيع عياد
 اشراف: الدكتور سمير عبد اللطيف البرغوثي
 
 الملخص
في المجالين الطبي  ذات أهميه كبيرة ).pps secymotpertS(تعد البكتيريا من فصيلة ستريبتومايسز 
الفطريات، ،المواد الي تصنف كمضادات حيوية بما فيها مضادات البكتيريااذ انها تنتج العديد من  ،والزراعي
 الطفيليات، والفيروسات. كما انها تنتج العديد من المضادات للافات الزراعية ومضادات للخلايا السرطانية.
ثير من ان ظهور الطفرات في بعض انواع البكتيريا التي تقاوم انواع عديدة من المضادات الحيوية اثارت الك
 المشاكل الصحية، ولذلك كان و مازال من المهم ايجاد بدائل لها لتسد الفراغات و تحل هذه المشكلة.
تم اكتشاف الستربتومايسن وهو اول مضاد حيوي اكتشف ويصنع من هذه البكتيريا. و منذ ذلك  2491في 
والمواد الفعالة التي تنتجها واعتبرت الوقت بدأ الباحثون بدراسة الستريبتومايسز واستخراج المضادات الحيوية 
 على انها اكثر فصيلة منتجة للمضادات الحيوية.
تم عزلها من مسحوق الكاكاو  هذه الدراسة تهدف الى استخراج احد المواد الحيوية الفعالة من بكتيريا التي
وسميت في هذه الدراسة على انها ستريبتومايسز التجاري وتم تصنيفها وفقا لبرنامج الستريبتومايسز العالمي 
وبعد ذلك تم دراسة تأثير المضاد الحيوي الذي تنتجه على اكثر من نوع من البكتيريا عن   )79CBUQ(
طريق اخذ قطعة من الاجر الذي نمت عليه هذه البكتيريا و انتشر مضادها الحيوي فيها ووضع هذه القطع 
 سة منطقة التثبيط حول هذه القطع.على سطح  مزروع عليه انواع مختلفة من البكتيريا و درا
 
